1-6 of 6
Henry Adewoye
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exposure-Response of Idelalisib Administered in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Chronic Lymphocytic Leukemi

Free
Vinay Manu Daryani, PharmD, Shringi Sharma, PhD, Guan Xing, PhD, Jeffrey Silverman, PhD, Adeboye Henry Adewoye, MD, Anita Mathias, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5344.
https://doi.org/10.1182/blood.V130.Suppl_1.5344.5344
Published: 2017
Journal Articles

A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care

Free
Jacob D. Soumerai, MD, Ai Ni, PhD, Mohamed Darif, PhD, Anil Londhe, PhD, Guan Xing, PhD, Julie Huang, PhD, Ming Lin, PhD, John C. Byrd, MD, Asher A. Chanan-Khan, MD, Richard R. Furman, MD, Michael Hallek, MD, Peter Hillmen, MBChB, PhD, Jeffrey Jones, MD, Jeffrey P. Sharman, MD, Lucille Ferrante, MD, Vijay Reddy, MD PhD, Lyndah K. Dreiling, MD, Henry Adewoye, MD, Ronald Dubowy, MD, Angela Howes, PhD, Danelle F. James, MD MAS, Andrew D. Zelenetz, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4303.
https://doi.org/10.1182/blood.V130.Suppl_1.4303.4303
Published: 2017
Journal Articles

Updated Analysis of Overall Survival in Randomized Phase III Study of Idelalisib in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL

Free
Andrew D. Zelenetz, Jennifer R. Brown, Julio Delgado, Herbert Eradat, Paolo Ghia, Abraham Jacob, Wojciech Jurczak, Javier Loscertales, Donald MacDonald, Franck Morschhauser, Javier De la Serna, Mazyar Shadman, Christopher Pocock, Adeboye Henry Adewoye, Yeonhee Kim, David Simpson, Stephan Stilgenbauer
Journal: Blood
Blood (2016) 128 (22): 231.
https://doi.org/10.1182/blood.V128.22.231.231
Published: 2016
Journal Articles

A Retrospective Analysis of Pneumocystis Jirovecii Pneumonia Infection in Patients Receiving Idelalisib in Clinical Trials

Free
Laurie H Sehn, MD, Michael Hallek, Wojciech Jurczak, Jennifer R. Brown, Paul M. Barr, John Catalano, Steven E. Coutre, MD, Richard R. Furman, Nicole Lamanna, Ysebaert Loïc, Andrew D. Zelenetz, Jeffrey P. Sharman, Sven DeVos, Adeboye Henry Adewoye, Yeonhee Kim, Ian W. Flinn, MD PhD, Gilles A. Salles
Journal: Blood
Blood (2016) 128 (22): 3705.
https://doi.org/10.1182/blood.V128.22.3705.3705
Published: 2016
Journal Articles

Phase 1b and Pharmacokinetic Study of Idelalisib in Japanese Patients with Relapsed or Refractory (R/R) Indolent B-Cell Non-Hodgkin Lymphoma (iNHL) or Chronic Lymphocytic Leukemia (CLL)

Free
Tomohiro Kinoshita, MD PhD, Noriko Fukuhara, MD PhD, Hirokazu Nagai, MD PhD, Koji Izutsu, MD, Yukio Kobayashi, MD PhD, Yusuke Higuchi, MD, Hideo Harigae, MD, Takashi Tokunaga, MD PhD, Henry Adewoye, MD, Michelle Robeson, ND, Shringi Sharma, PhD, Masato Fukui, MD, Jie Gao, PhD, Christine Christenson, Kensei Tobinai, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5089.
https://doi.org/10.1182/blood.V126.23.5089.5089
Published: 2015
Journal Articles

Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab In Patients With Relapsed/Refractory CLL Demonstrates Efficacy and Tolerability

Free
Jacqueline C. Barrientos, MD, Nina D. Wagner-Johnston, MD, Sven De Vos, MD, PhD, Steven E. Coutre, MD, Marshall T. Schreeder, MD, MPH, Ian Flinn, MD, PhD, Jeff P. Sharman, MD, Kanti R. Rai, MD, John P. Leonard, M.D., Roger Dansey, MD, Yeonhee Kim, PhD, Leanne M. Holes, Henry Adewoye, MD, Richard R. Furman, MD
Journal: Blood
Blood (2013) 122 (21): 4176.
https://doi.org/10.1182/blood.V122.21.4176.4176
Published: 2013